Want to see RNXT full AI Analyst Report?
Total Valuation
RenovoRx has a market cap or net worth of $76.27M. The enterprise value is $37.26.
Market Cap$76.27M
Enterprise Value$37.26
Share Statistics
RenovoRx has 45,129,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,129,510
Owned by Insiders3.70%
Owned by Institutions14.25%
Financial Efficiency
RenovoRx’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -200.55%.
Return on Equity (ROE)-2.06
Return on Assets (ROA)-1.38
Return on Invested Capital (ROIC)-200.55%
Return on Capital Employed (ROCE)-2.04
Revenue Per Employee66.06K
Profits Per Employee-656.94K
Employee Count17
Asset Turnover0.14
Inventory Turnover1.73
Valuation Ratios
The current PE Ratio of RenovoRx is ―. RenovoRx’s PEG ratio is 0.19.
PE Ratio―
PS Ratio26.43
PB Ratio5.47
Price to Fair Value5.47
Price to FCF-2.70
Price to Operating Cash Flow-6.74
PEG Ratio0.19
Income Statement
In the last 12 months, RenovoRx had revenue of 1.12M and earned -11.17M in profits. Earnings per share was -0.32.
Revenue1.12M
Gross Profit796.00K
Operating Income-12.51M
Pretax Income-11.17M
Net Income-11.17M
EBITDA-11.17M
Earnings Per Share (EPS)-0.32
Cash Flow
In the last 12 months, operating cash flow was -11.87M and capital expenditures -71.00K, giving a free cash flow of -11.94M billion.
Operating Cash Flow-11.87M
Free Cash Flow-11.94M
Free Cash Flow per Share-0.26
Dividends & Yields
RenovoRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.88
52-Week Price Change30.00%
50-Day Moving Average1.34
200-Day Moving Average1.03
Relative Strength Index (RSI)51.16
Average Volume (3m)1.20M
Important Dates
RenovoRx upcoming earnings date is Nov 16, 2026, After Close (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 16, 2026
Ex-Dividend Date―
Financial Position
RenovoRx as a current ratio of 4.02, with Debt / Equity ratio of 2.88%
Current Ratio4.02
Quick Ratio3.93
Debt to Market Cap<0.01
Net Debt to EBITDA0.61
Interest Coverage Ratio0.00
Taxes
In the past 12 months, RenovoRx has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
RenovoRx EV to EBITDA ratio is -2.05, with an EV/FCF ratio of -2.08.
EV to Sales20.37
EV to EBITDA-2.05
EV to Free Cash Flow-2.08
EV to Operating Cash Flow-2.08
Balance Sheet
RenovoRx has $9.48M in cash and marketable securities with $259.00K in debt, giving a net cash position of $9.22M billion.
Cash & Marketable Securities$9.48M
Total Debt$259.00K
Net Cash$9.22M
Net Cash Per Share$0.20
Tangible Book Value Per Share$0.15
Margins
Gross margin is 84.41%, with operating margin of -1113.98%, and net profit margin of -994.48%.
Gross Margin84.41%
Operating Margin-1113.98%
Pretax Margin-994.48%
Net Profit Margin-994.48%
EBITDA Margin-994.30%
EBIT Margin-994.48%
Analyst Forecast
The average price target for RenovoRx is $7.13, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.13
Price Target Upside401.76% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast198.49%
EPS Growth Forecast16.29%